A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,548,970 shares of AMGN stock, worth $523 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,548,970
Previous 1,660,042 6.69%
Holding current value
$523 Million
Previous $472 Million 2.54%
% of portfolio
0.36%
Previous 0.33%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$262.75 - $319.31 $29.2 Million - $35.5 Million
-111,072 Reduced 6.69%
1,548,970 $484 Million
Q1 2024

Apr 19, 2024

BUY
$268.87 - $324.56 $840,756 - $1.01 Million
3,127 Added 0.19%
1,660,042 $472 Million
Q4 2023

Jan 30, 2024

SELL
$255.7 - $288.46 $7.04 Million - $7.95 Million
-27,546 Reduced 1.64%
1,656,915 $477 Million
Q3 2023

Oct 30, 2023

SELL
$218.65 - $271.46 $3.68 Million - $4.57 Million
-16,844 Reduced 0.99%
1,684,461 $453 Million
Q2 2023

Jul 31, 2023

SELL
$214.27 - $253.37 $44 Million - $52 Million
-205,280 Reduced 10.77%
1,701,305 $378 Million
Q1 2023

Apr 27, 2023

BUY
$225.79 - $275.2 $11.7 Million - $14.3 Million
51,857 Added 2.8%
1,906,585 $461 Million
Q4 2022

Jan 30, 2023

SELL
$229.03 - $291.01 $93,902 - $119,314
-410 Reduced 0.02%
1,854,728 $487 Million
Q3 2022

Oct 21, 2022

SELL
$224.46 - $253.15 $10.5 Million - $11.8 Million
-46,788 Reduced 2.46%
1,855,138 $418 Million
Q2 2022

Jul 26, 2022

BUY
$230.71 - $256.74 $889,387 - $989,732
3,855 Added 0.2%
1,901,926 $463 Million
Q1 2022

Apr 27, 2022

SELL
$219.27 - $242.57 $22.1 Million - $24.5 Million
-101,011 Reduced 5.05%
1,898,071 $459 Million
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $65.3 Million - $74.7 Million
-328,245 Reduced 14.1%
1,999,082 $450 Million
Q3 2021

Oct 25, 2021

SELL
$212.27 - $248.7 $50.2 Million - $58.9 Million
-236,723 Reduced 9.23%
2,327,327 $495 Million
Q2 2021

Aug 02, 2021

SELL
$233.58 - $259.14 $33.1 Million - $36.8 Million
-141,869 Reduced 5.24%
2,564,050 $625 Million
Q1 2021

Apr 30, 2021

BUY
$221.91 - $258.6 $1.66 Million - $1.94 Million
7,487 Added 0.28%
2,705,919 $673 Million
Q4 2020

Feb 05, 2021

SELL
$216.38 - $257.67 $54.8 Million - $65.3 Million
-253,424 Reduced 8.59%
2,698,432 $620 Million
Q3 2020

Oct 30, 2020

BUY
$234.65 - $260.95 $60.3 Million - $67 Million
256,787 Added 9.53%
2,951,856 $750 Million
Q2 2020

Jul 27, 2020

BUY
$197.81 - $242.74 $35.1 Million - $43.1 Million
177,537 Added 7.05%
2,695,069 $636 Million
Q1 2020

Apr 27, 2020

BUY
$182.24 - $241.7 $24.1 Million - $31.9 Million
132,164 Added 5.54%
2,517,532 $510 Million
Q4 2019

Jan 31, 2020

BUY
$189.21 - $243.2 $1.9 Million - $2.44 Million
10,043 Added 0.42%
2,385,368 $575 Million
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $12.3 Million - $14.7 Million
-70,565 Reduced 2.89%
2,375,325 $460 Million
Q2 2019

Jul 29, 2019

SELL
$166.7 - $195.41 $8.16 Million - $9.57 Million
-48,969 Reduced 1.96%
2,445,890 $451 Million
Q1 2019

May 08, 2019

BUY
$180.87 - $203.88 $1.16 Million - $1.3 Million
6,388 Added 0.26%
2,494,859 $474 Million
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $65 Million - $75.8 Million
364,214 Added 17.15%
2,488,471 $475 Million
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $3.5 Million - $3.94 Million
18,872 Added 0.9%
2,124,257 $440 Million
Q2 2018

Aug 01, 2018

BUY
$166.05 - $186.51 $20.8 Million - $23.3 Million
125,049 Added 6.31%
2,105,385 $389 Million
Q1 2018

May 01, 2018

SELL
$169.43 - $198.0 $19.5 Million - $22.8 Million
-114,901 Reduced 5.48%
1,980,336 $338 Million
Q4 2017

Feb 06, 2018

BUY
$168.79 - $188.59 $3.54 Million - $3.95 Million
20,969 Added 1.01%
2,095,237 $364 Million
Q3 2017

Nov 07, 2017

SELL
$167.29 - $191.0 $5.52 Million - $6.3 Million
-32,967 Reduced 1.56%
2,074,268 $387 Million
Q2 2017

Aug 07, 2017

BUY
N/A
2,107,235
2,107,235 $363 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $180B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.